Loading the section…

CBLL: financial statements from SEC — TradeAlmanac

CBLL

CeriBell, Inc.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	31/03/2026	30/09/2025	30/06/2025	31/03/2025	30/09/2024	30/06/2024
Revenue	26M	23M	21M	20M	17M	15M
Cost of revenue	3M	3M	3M	2M	2M	2M
Gross profit	23M	20M	19M	18M	15M	13M
Research and development	6M	5M	5M	4M	3M	3M
Selling, general and administrative	15M	11M	11M	10M	9M	8M
Operating expenses	44M	35M	34M	32M	25M	22M
Operating income	−21M	−15M	−15M	−14M	−10M	−8M
Pre-tax income	−20M	−13M	−14M	−13M	−10M	−9M
Net income	−20M	−13M	−14M	−13M	−10M	−9M
Earnings per share	−0.52	−0.37	−0.38	−0.36	−1.85	−1.61
Earnings per share, diluted	−0.52	−0.37	−0.38	−0.36	−1.85	−1.61
Weighted average shares	38M	37M	36M	36M	6M	6M
Weighted average shares, diluted	38M	37M	36M	36M	6M	6M

Balance sheet

Metric	31/03/2026	31/12/2025	30/09/2025	30/06/2025	31/03/2025	31/12/2024	30/09/2024	30/06/2024
Cash and equivalents	45M	40M	24M	40M	153M	194M	14M	24M
Short-term investments	96M	119M	145M

Cash flow

Metric	31/03/2026	31/03/2025
Operating cash flow	−19M	−11M
Depreciation and amortisation	239,000	335,000
Share-based compensation	4M	2M
Capital expenditure	125,000	148,000
Investing cash flow	22M	−30M
Financing cash flow	2M

Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator